Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 57.23

+0.4%

2:15 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Frank Sully	1/26/2022 3:43:36 AM
	of 52153

Is CRISPR Therapeutics a Buy?If you're willing to speculate, yes. Alex Carchidi Jan 24, 2022 Key PointsBiotech stocks like CRISPR Therapeutics ebb and flow based on the market's reactions to their clinical trial results.Collaboration revenue and cash will easily keep the company afloat while it works out the kinks with CTX110.This isn't a stock for the faint of heart, but it could be a gold mine.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next